BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 14496307)

  • 1. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
    de SALCEDO ; SOUSA CG
    J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the anabolic action of 19-nortestosterone phenylpropionate. Preliminary note].
    de SALCEDO ; BORGES F; GODINHO P
    J Med (Oporto); 1960 Nov; 43():599-600. PubMed ID: 13831238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and radiological experimentation in pediatrics with a new anabolic agent by oral route: 17alpha-methyl-17beta-hydroxyndrosta-1, 4-dien-3-one (methandrostenolone)].
    ROSSO P; PRZYGODA P
    Sem Med; 1961 Oct; 119():1219-27. PubMed ID: 14494328
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES ON THE NITROGEN BALANCE IN THE HUMAN DURING LONG-TERM TREATMENT WITH DIFFERENT ANABOLIC AGENTS UNDER STRICTLY STANDARDIZED CONDITIONS.
    SAARNE A; BJERSTAF L; EKMAN B
    Acta Med Scand; 1965 Feb; 177():199-211. PubMed ID: 14279501
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures.
    Caraci F; PistarĂ  V; Corsaro A; Tomasello F; Giuffrida ML; Sortino MA; Nicoletti F; Copani A
    J Neurosci Res; 2011 Apr; 89(4):592-600. PubMed ID: 21290409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results and problems in therapy with protein-anabolic steroids based on experiences with methandrostenolone (dianabol/Ciba)].
    GEYER G; JESSERER H
    Dtsch Arch Klin Med; 1962; 208():252-78. PubMed ID: 13898157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methandrostenolone in anabolic therapy in gynecology].
    MISURALE F; POMINI P
    Riv Ostet Ginecol Prat; 1960 Dec; 42():975-80. PubMed ID: 13771317
    [No Abstract]   [Full Text] [Related]  

  • 8. [New synthetic anabolic preparation: methandrostenolone].
    MOSSO HE; PERGOLA F
    Dia Med; 1961 Mar; 33():208-14. PubMed ID: 13773155
    [No Abstract]   [Full Text] [Related]  

  • 9. [COMPARATIVE STUDY OF THE THERAPEUTIC ACTIVITY OF CERTAIN ANABOLIC STEROIDS WITH POTENTIALITY FOR BONE].
    ISEMEIN L; TABAU R
    Rhumatologie; 1964 Oct; 16():371-5. PubMed ID: 14225657
    [No Abstract]   [Full Text] [Related]  

  • 10. MANAGEMENT OF RETARDED GROWTH WITH ANABOLIC STEROIDS.
    GOTH E
    Ther Hung; 1964; 12():140-3. PubMed ID: 14258786
    [No Abstract]   [Full Text] [Related]  

  • 11. [4-CHLORO-DELTA-1-METHYLTESTOSTERONE (ORAL TURINABOL), A NEW EFFECTIVE ORAL ANABOLIC STEROID].
    DOERNER G
    Dtsch Gesundheitsw; 1965 Apr; 20():670-4. PubMed ID: 14304129
    [No Abstract]   [Full Text] [Related]  

  • 12. [STEROIDAL ETHERS: EFFECT OF SOME ANABOLIC STEROIDS ON THE GROWTH CURVE AND WEIGHT OF VARIOUS ORGANS IN INTACT ADULT RATS].
    GALLETTI F; ERCOLI A
    Boll Soc Ital Biol Sper; 1963 Dec; 39():2095-7. PubMed ID: 14156769
    [No Abstract]   [Full Text] [Related]  

  • 13. USE OF METHANDROSTENOLONE IN CHRONIC SCHIZOPHRENIC PATIENTS.
    HECKEL RV; CLARK DT; BERMAN M; HALL RC
    Dis Nerv Syst; 1964 Mar; 25():171-2. PubMed ID: 14127899
    [No Abstract]   [Full Text] [Related]  

  • 14. [The retention of BSF during treatment with a new synthetic anabolic agent: methandrostenolone].
    MASTRANDREA G; MAZZETTI M
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13(6)Suppl():48-50. PubMed ID: 14470994
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE EFFECT OF ANABOLIC AGENTS ON THE METABOLISM OF CHILDREN. RESULTS OF COMPARATIVE STUDIES IN SERUM CHEMISTRY].
    BECKMANN R; KLEINSCHMIDT H
    Munch Med Wochenschr; 1963 Dec; 105():2442-8. PubMed ID: 14118257
    [No Abstract]   [Full Text] [Related]  

  • 16. ANABOLIC STEROIDS IN THE MANAGEMENT OF THE DIABETIC PATIENT.
    TAINTER ML; ARNOLD A; BEYLER AL; POTTS GO; ROTH CH
    N Y State J Med; 1964 Apr; 64():1001-9. PubMed ID: 14141174
    [No Abstract]   [Full Text] [Related]  

  • 17. [RESEARCH ON FATIGUE PREVENTION. (ACTION OF 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE)].
    MAGLIO A; POTENZA P; FRANCESCONI A
    Ann Med Nav (Roma); 1963; 68():797-802. PubMed ID: 14089321
    [No Abstract]   [Full Text] [Related]  

  • 18. [CLINICAL EXPERIMENTATION OF A PREPARATION FOR TOPICAL USE CONTAINING AN ANABOLIZING STEROID, METHANDROSTENOLONE, IN THE TREATMENT OF CUTANEOUS ULCERATIONS].
    GIACOMETTI F
    Rass Dermatol Sifilogr; 1964; 17():41-54. PubMed ID: 14141267
    [No Abstract]   [Full Text] [Related]  

  • 19. [PRELIMINARY TRIAL IN DERMATOLOGY OF A NEW COMPOUND OF DEXAMETHASONE AND AN ANABOLIC].
    MAZZINI MA
    Sem Med; 1963 Sep; 123():1060-1. PubMed ID: 14091141
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIENCES WITH THE ANABOLIC STEROID METHANDROSTENOLONE].
    KRONIG OJ; DEKKERS HJ; van der PLAATS AB; VAN LOOKERENCAMPAGNE
    Geneeskd Gids; 1964 Mar; 42():116-23. PubMed ID: 14145741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.